Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray.

Latrice HogueLeah A CardwellCatherine RoachKayla H FelixElias OussedikIrma RichardsonSteven R Feldman

Published in: Journal of cutaneous medicine and surgery (2018)

Patients with "treatment-resistant" Ps and AD generally responded well to the use of desoximetasone spray in the trial setting. This may be due to better adherence in the study environment or patients' preference for the spray vehicle. Patient reminders contributed to improved clinical outcomes in Ps and AD patients with "treatment-resistant" disease.

Keyphrases

atopic dermatitis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
clinical trial
prognostic factors
type diabetes
case report